The way a cancer patient moves through a center — from first abnormal finding, through diagnosis, treatment planning, active treatment, and survivorship — is the single most consequential input to a cancer-center floor plan. Oncology is the one service line where a clinic is not a collection of exam rooms but an orchestration problem: a frail, often immunocompromised patient may need a clinic visit, a blood draw, a pharmacy turnaround, an infusion chair, and an imaging or radiation appointment all in the same half-day, and the building either makes that choreography effortless or it makes every visit an ordeal. This article describes the oncology patient journey, the flow and adjacency logic that journey imposes on the plan, and the multidisciplinary-clinic operating model that has become the de facto standard for modern cancer programs.

The oncology patient journey

A cancer journey is long, episodic, and emotionally charged. Unlike an acute encounter, a single patient relationship can span years and hundreds of visits. Designing for oncology means designing for a recurring visitor who becomes intimately familiar with the building, who arrives fatigued or in pain, and whose tolerance for confusion, long walks, and crowded waiting is low. The journey decomposes into recognizable phases, each with its own spatial demands.

Phase What happens Primary spaces engaged
Suspicion / screening Abnormal screening result or symptomatic referral; first imaging and biopsy Imaging, procedure/biopsy room, intake/navigation
Diagnosis & staging Pathology, additional imaging (CT/MRI/PET), biomarker and molecular testing Lab/specimen collection, imaging, multidisciplinary conference room
Treatment planning Tumor-board review; consultation with medical, radiation, and surgical oncology; consent Consult/exam rooms, conference room, navigation, financial counseling
Active treatment Systemic therapy (infusion), radiation therapy, surgery, or combinations — often concurrent Infusion suite, radiation-oncology vaults, clinic exam, pharmacy, lab
Monitoring & assessment On-treatment visits, response imaging, toxicity management, dose adjustments Clinic exam, lab, imaging, symptom-management/urgent slots
Survivorship or palliation Surveillance, survivorship care planning, supportive/palliative care, or end-of-life support Clinic exam, supportive-care/integrative spaces, social work

The construction-relevant insight is that active treatment is not a single destination. A patient in active treatment cycles repeatedly through lab, clinic, pharmacy, and infusion (and, for combined-modality cases, radiation) — frequently within one appointment block. The plan must compress this loop, not stretch it across a campus.

The same-day "lab → clinic → pharmacy → treatment" loop

The defining operational pattern of medical oncology is the same-day visit, in which a patient's blood is drawn, results are reviewed by the clinician, the chemotherapy regimen is verified and released by pharmacy, and the patient is treated — all in sequence, all in one trip. This loop drives more of the oncology floor plate than any single room type.

A typical sequence on an infusion day:

  1. Arrival and check-in — registration, insurance/financial verification, and orientation by a navigator.
  2. Lab draw — venous access (often through an implanted port) and a same-day CBC and chemistry panel; turnaround of roughly 30-60 minutes is the planning target.
  3. Clinical assessment — the oncologist or advanced-practice provider reviews counts, assesses toxicity and performance status, and confirms the patient is fit to treat that day.
  4. Pharmacy verification and compounding — only after the clinician's "treat" decision does the pharmacy begin sterile compounding of the hazardous antineoplastic preparation; compounding cannot run far ahead of the decision because drugs are expensive, short-dated once mixed, and dosed to that day's labs and weight.
  5. Infusion — the patient is seated in a chair or bay; pre-medications, the regimen, and post-treatment observation can range from under an hour to a full day.
  6. Discharge / next-visit scheduling — wrap-up, supportive-care referrals, and booking of the next cycle.

Each handoff in this chain is a queue, and each queue is a place where a fragile patient waits. Good oncology planning attacks the queues: it co-locates the lab draw with the clinic, it shortens the physical distance between pharmacy and the infusion suite, and it gives the program room to overlap steps so that the chair is not idle while pharmacy compounds and the patient is not idle while the chair is occupied by someone else. The dependency of compounding on the clinical decision is the reason pharmacy turnaround is a chronic throughput constraint — and the reason pharmacy-to-infusion adjacency (covered in the pharmacy, lab, and imaging adjacency sibling article) is treated as a near-hard requirement rather than a convenience.

The multidisciplinary-clinic operating model

Modern cancer care is delivered by a team, not a sequence of independent specialists. The multidisciplinary model — strongly reinforced by accreditation programs such as the American College of Surgeons Commission on Cancer and the NCI-designated comprehensive cancer center criteria — expects medical oncology, radiation oncology, surgical oncology, pathology, radiology, and a deep bench of supportive disciplines (nursing, navigation, pharmacy, social work, nutrition, genetic counseling, palliative care, rehabilitation, and clinical research) to coordinate around the individual patient. This model has two distinct architectural expressions.

The disease-site / "patient-stays-put" clinic. In the most patient-centered version, exam rooms are organized by disease site (breast, thoracic, GI, GU, head-and-neck, hematologic malignancies) rather than by physician, and the patient remains in one room while the medical oncologist, radiation oncologist, surgeon, nurse navigator, and others rotate through. This onstage/offstage arrangement requires: